C82.90
Follicular lymphoma, unspecified, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that begins in the lymphatic system, particularly affecting lymphocytes, a type of white blood cell involved in the immune response. Classified under the ICD-10 code C82.90, this lymphoma is called 'unspecified' because it can occur in various parts of the body and may not have specific details documented. It generally progresses slowly and is considered a form of non-Hodgkin lymphoma. Understanding the basics of follicular lymphoma helps patients recognize its potential signs and understand the context of medical diagnosis and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations: Changes in specific genes like BCL2 are common in follicular lymphoma. Age-related factors: Most cases occur in middle-aged and older adults. Family history: A history of lymphoma or other blood disorders can increase risk. Environmental exposures: Long-term exposure to certain chemicals, such as pesticides or solvents, may contribute. Immune system dysfunction: Conditions that impair immune function could predispose individuals.
Key Symptoms: Painless swelling of lymph nodes, often noticed in the neck, armpits, or groin. Persistent fatigue and weakness. Unexplained weight loss. Fever that recurs without explanation. Night sweats and chills. Feeling full or discomfort due to enlarged lymph nodes pressing on other organs. In some cases, symptoms may not be evident in early stages.
Diagnostic & Treatment
Diagnosis Path: Diagnosing follicular lymphoma involves several steps. Healthcare providers typically perform physical examinations to check for swollen lymph nodes and may order additional tests, such as blood tests to analyze blood cell counts. Imaging studies like CT scans or PET scans help identify the extent and location of the disease. A definitive diagnosis usually requires a biopsy, where a small sample of lymph node tissue is examined microscopically for characteristic lymphoma cells. Additional tests, including immunophenotyping and molecular studies, can help confirm the subtype and prognosis of the disease.
Treatment Protocols: Treatment options depend on various factors, including the disease's stage, symptoms, and overall health of the patient. Because follicular lymphoma is often slow-growing, doctors may recommend a 'watch and wait' approach in early, asymptomatic cases. When treatment is necessary, options include chemotherapy, immunotherapy (such as monoclonal antibodies like rituximab), targeted therapy, or radiation therapy. In some cases, stem cell transplants may be considered, especially if the disease progresses or relapses after initial treatment. Regular monitoring and follow-up are essential aspects of managing follicular lymphoma, emphasizing the importance of ongoing medical care.
Clinical Advice & FAQs
Billing Guidance
Is C82.90 a billable ICD-10 code?
Yes, C82.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.90?
Clinical documentation must specify the nature of Follicular lymphoma, unspecified, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
